Autophagy facilitates the development of resistance to the tumor necrosis factor superfamily member TRAIL in breast cancer

International Journal of Oncology

Volumn 46, Issue 3, 2015, Pages 1286-1294

  Lv, Shangge ^a,b   Wang, Xiaolong ^a   Zhang, Ning ^a   Sun, Mingjuan ^a   Qi, Wenwen ^b   Li, Yaming ^b   Yang, Qifeng ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Autophagy; Breast cancer; Drug resistance; Reverse; TRAIL

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CHLOROQUINE; DANSYLCADAVERINE; PROTEIN P62; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; ANTINEOPLASTIC AGENT; CHROMONE DERIVATIVE; MORPHOLINE DERIVATIVE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; BREAST CANCER; CANCER CELL CULTURE; CELL PROLIFERATION; CELL VACUOLE; CELL VIABILITY; CONTROLLED STUDY; ELECTRON MICROSCOPY; FLUORESCENCE; HUMAN; HUMAN CELL; LIGHT CHAIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; STAINING; UPREGULATION; APOPTOSIS; BREAST NEOPLASMS; CELL SURVIVAL; DRUG EFFECTS; DRUG POTENTIATION; DRUG RESISTANCE; FEMALE; METABOLISM; PATHOLOGY; PHAGOSOME; PHYSIOLOGY; TUMOR CELL CULTURE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; AUTOPHAGY; BREAST NEOPLASMS; CELL SURVIVAL; CHLOROQUINE; CHROMONES; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; FEMALE; HUMANS; MORPHOLINES; PHAGOSOMES; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR CELLS, CULTURED;

EID: 84921915863     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2812     Document Type: Article

References (28)

1. Mizushima N: Physiological functions of autophagy. Curr Top Microbiol Immunol 335: 71-84, 2009.
2. Mathew R, Karantza-Wadsworth V and White E: Role of autophagy in cancer. Nat Rev Cancer 7: 961-967, 2007.
3. Levine B and Kroemer G: Autophagy in the pathogenesis of disease. Cell 132: 27-42, 2008.
4. Eskelinen EL: The dual role of autophagy in cancer. Curr Opin Pharmacol 11: 294-300, 2011.
5. Degenhardt K, Mathew R, Beaudoin B, et al: Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 10: 51-64, 2006.
6. Amaravadi RK, Lippincott-Schwartz J, Yin XM, et al: Principles and current strategies for targeting autophagy for cancer treatment. Clin Cancer Res 17: 654-666, 2011.
7. Qadir MA, Kwok B, Dragowska WH, et al: Macroautophagy inhibition sensitizes tamoxifen-resistant breast cancer cells and enhances mitochondrial depolarization. Breast Cancer Res Treat 112: 389-403, 2008.
8. Wiley SR, Schooley K, Smolak PJ, et al: Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3: 673-682, 1995.
9. Ashkenazi A, Pai RC, Fong S, et al: Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest 104: 155-162, 1999.
10. Walczak H, Miller RE, Ariail K, et al: Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 5: 157-163, 1999.
11. Mahalingam D, Szegezdi E, Keane M, de Jong S and Samali A: TRAIL receptor signalling and modulation: are we on the right TRAIL? Cancer Treat Rev 35: 280-288, 2009.
12. Abdulghani J and El-Deiry WS: TRAIL receptor signaling and therapeutics. Expert Opin Ther Targets 14: 1091-1108, 2010.
13. Menke C, Bin L, Thorburn J, Behbakht K, Ford HL and Thorburn A: Distinct TRAIL resistance mechanisms can be overcome by proteasome inhibition but not generally by synergizing agents. Cancer Res 71: 1883-1892, 2011.
14. Keane MM, Ettenberg SA, Nau MM, Russell EK and Lipkowitz S: Chemotherapy augments TRAIL-induced apoptosis in breast cell lines. Cancer Res 59: 734-741, 1999.
15. Yoshida T, Zhang Y, Rivera Rosado LA and Zhang B: Repeated treatment with subtoxic doses of TRAIL induces resistance to apoptosis through its death receptors in MDA-MB-231 breast cancer cells. Mol Cancer Res 7: 1835-1844, 2009.
16. Rahman M, Davis SR, Pumphrey JG, et al : TRAIL induces apoptosis in triple-negative breast cancer cells with a mesenchymal phenotype. Breast Cancer Res Treat 113: 217-230, 2009.
17. Bossen C, Tardivel A, Willen L, et al: Mutation of the BAFF furin cleavage site impairs B-cell homeostasis and antibody responses. Eur J Immunol 41: 787-797, 2011.
18. Kim SH, Kim K, Kwagh JG, et al: Death induction by recombinant native TRAIL and its prevention by a caspase 9 inhibitor in primary human esophageal epithelial cells. J Biol Chem 279: 40044-40052, 2004.
19. Biederbick A, Kern HF and Elsässer HP: Monodansylcadaverine (MDC) is a specific in vivo marker for autophagic vacuoles. Eur J Cell Biol 66: 3-14, 1995.
20. Mariño G, Ugalde AP, Salvador-Montoliu N, et al: Premature aging in mice activates a systemic metabolic response involving autophagy induction. Hum Mol Genet 17: 2196-2211, 2008.
21. Zhang N, Wang X, Huo Q, et al: The oncogene metadherin modulates the apoptotic pathway based on the tumor necrosis factor superfamily member TRAIL (Tumor Necrosis Factor-related Apoptosis-inducing Ligand) in breast cancer. J Biol Chem 288: 9396-9407, 2013.
22. Klionsky DJ and Emr SD: Autophagy as a regulated pathway of cellular degradation. Science 290: 1717-1721, 2000.
23. Kelekar A: Introduction to the review series Autophagy in Higher Eukaryotes - a matter of survival or death. Autophagy 4: 555-556, 2008.
24. Pankiv S, Clausen TH, Lamark T, et al: p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem 282: 24131-24145, 2007.
25. Valentim L, Laurence KM, Townsend PA, et al: Urocortin inhibits Beclin1-mediated autophagic cell death in cardiac myocytes exposed to ischaemia/reperfusion injury. J Mol Cell Cardiol 40: 846-852, 2006.
26. Mizushima N, Yoshimori T and Levine B: Methods in mammalian autophagy research. Cell 140: 313-326, 2010.
27. Sternberg CN, Donat SM, Bellmunt J, et al: Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer. Urology 69 (Suppl 1): S62-S79, 2007.
28. Yang ZJ, Chee CE, Huang S and Sinicrope FA: The role of autophagy in cancer: therapeutic implications. Mol Cancer Ther 10: 1533-1541, 2011.